Product Description
Since last manyA years SaintroyA LifescienceA is leading manufacture, export andsupplier ofA Vinorelbine InjectionA from Surat, Gujarat, India. Vinorelbine Injection used to treat a number of types of cancer. This includes breast cancer and non-small cell lung cancer.
Tags: Vinorelbine Injection manufacturer, Vinorelbine Injection exporter,Vinorelbine Injection supplier, and Vinorelbine Injection, whogmp approved Vinorelbine InjectionA manufacturer and supplier, Vinorelbine Injection distributor, Vinorelbine InjectionA shipper, Vinorelbine Injection 5 ml Vinorelbine Injection A A 5 mlA supplier,Vinorelbine Injection 5 ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility inA Gujarat, India.
Registration: Saintroy LifescienceA is interested inregistration of own brand or customer brands in ministryA of health of clientsA country and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export CountryA :Saintroy Lifescience Vinorelbine InjectionA export to USA, Canada, Germany, Europe, France, Ghana, Nigeria,Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile,Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore, Malaysia, HongKong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau, Congo,Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua, Salvador,Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine, Algeria, Guyana,Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.A
Precise Chemotherapy DeliveryVinorelbine Injection is specifically designed for intravenous use in the treatment of non-small cell lung cancer and metastatic breast cancer. Its pharmaceutical-grade quality ensures consistent efficacy and safety, provided it is administered solely by qualified healthcare professionals in compliant medical facilities.
Optimal Storage and HandlingTo maintain its quality and effectiveness, Vinorelbine Injection should be stored in a cool, dry environment. The glass vial with a rubber stopper ensures both sterility and safe storage. Attention to these requirements preserves the medication's potency throughout its two-year shelf life.
FAQ's of Vinorelbine Injection:
Q: How should Vinorelbine Injection be administered?
A: Vinorelbine Injection must be administered via intravenous infusion only by a qualified healthcare professional. It should never be given intrathecally, and its use is restricted to hospital settings to ensure patient safety.
Q: What conditions is Vinorelbine Injection used to treat?
A: This medication is indicated for the treatment of non-small cell lung cancer and metastatic breast cancer, offering therapeutic benefits for patients diagnosed with these types of cancer.
Q: When should Vinorelbine Injection not be used?
A: It should not be administered if you have a known hypersensitivity to Vinorelbine Tartrate or any of its components. It also must not be injected intrathecally under any circumstances.
Q: Where should Vinorelbine Injection be stored?
A: The vials should be stored in a cool and dry place, away from direct sunlight and heat sources, to maintain the medicine's integrity and safety over its two-year shelf life.
Q: What are the precautions during administration of Vinorelbine Injection?
A: The injection should only be handled and administered by healthcare professionals within a hospital setting. It is compatible only with normal saline and must not be mixed with other medications to prevent adverse reactions.
Q: What is the process for preparing Vinorelbine Injection for use?
A: Before administration, healthcare staff should inspect the vial for particulate matter or discoloration. The required dose is diluted in normal saline, using only sterile equipment to preserve the sterility and effectiveness of the medication.
Q: What benefits does Vinorelbine Injection provide in cancer therapy?
A: Vinorelbine Injection offers an effective option for managing non-small cell lung cancer and metastatic breast cancer, helping to slow disease progression and improve patient outcomes when administered as part of an overall treatment regimen.